LAKE FOREST, CA — David Ferrera, CEO of RC Medical, is calling for a greater emphasis on the translational discipline in medical device innovation, highlighting the often-overlooked gap between a promising idea and a product that successfully reaches patients. With nearly three decades in the industry, Ferrera believes many innovations fail not because of weak science, but because development loses sight of the end users. “In this business, a gr…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.